Comprehensive Cancer Centers of Nevada-Twain

Las Vegas, Nevada 89169

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Lymphoma, Metastatic Cholangiocarcinoma, Relapsed or Refractory Multiple Myeloma, Unresectable Cholangiocarcinoma

Studies at this site

• INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
• A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed